|
The Biomedical & Life Sciences Collection
New Releases for December
|
|
This month’s release to The Biomedical & Life Sciences Collection features talks on ocular immunology, antibiotic resistance testing, vaccine adjuvants, neoplasia, and much more.
|
This month’s addition to the series Periodic Reports: Advances in Clinical Interventions and Research Platforms is the two part talk on ‘Enhancing innate anti-tumour immunity: lessons from virotherapy and STING agonism’ by Prof. Kevin Harrington, Head of Division and Group Leader at The Institute of Cancer Research, UK. In his talk, Prof. Harrington discusses advancements in cancer immunotherapy using oncolytic viruses, toll-like receptor agonists, and STING agonists. He also explores the potential of these innate immune activators to enhance both local and systemic anti-tumour responses, particularly in combination therapies.
|
A complete list of the released talks is provided below.
|
Kind regards,
|
The Editorial Team
|
|
|
Bacterial nutrition: types and modes of feeding in prokaryotes
Dr. Primrose Freestone University of Leicester, UK
|
|
|
|
Enhancing innate anti-tumour immunity: lessons from virotherapy and STING agonism
Prof. Kevin Harrington The Institute of Cancer Research, UK
|
|
|
|
Lipoprotein(a)
Dr. Jaimini Cegla Imperial College Healthcare NHS Trust, UK
|
|
|
|
Ethical challenges in reproduction
Dr. Evie Kendal Swinburne University of Technology, Australia
|
|
|
|
Staphylococcus aureus
Dr. Sarah Fouch University of Portsmouth, UK
|
|
|
|
Ocular immunology: an overview of immune mechanisms operating in the eye
Dr. Eleftherios Agorogiannis Manchester Royal Eye Hospital, UK
|
|
|
|
Writing high-quality standard operating procedures
Mr. Atul Mathur Content Alive, Singapore
|
|
|
|
Innovative vaccines and viral pathogenesis: insights from recent monkeypox (Mpox) research
Prof. Rachel Roper East Carolina University, USA
|
|
|
|
Pathogenesis of neoplasia
Prof. Mark Arends The University of Edinburgh, UK
|
|
|
|
Characterizing barriers to care in migraine
Prof. Dawn C. Buse Albert Einstein College of Medicine, USA
|
|
|
|
Patient blood management
Dr. Mark T. Friedman NYU Grossman Long Island School of Medicine, USA
|
|
|
|
Clostridium perfringens
Dr. Sarah Fouch University of Portsmouth, UK
|
|
|
|
Innovative approaches to rapid antibiotic resistance testing
Dr. Robert Hammond University of St Andrews, UK
|
|
|
|
Novel & recent emerging adjuvants for vaccines
Prof. Dr. Timir Tripathi North-Eastern Hill University, India
|
|
|
|
Factor VII deficiency
Dr. Snejana Krassova Independent Consultant (Former Head of Medical Affairs – Haematology, Bayer), Switzerland
|
|
|
|
Building microbiological quality during the manufacture of medicines
Dr. Rajesh K. Gupta President, Biologics Quality & Regulatory Consultants, LLC, USA
|
|
|
|
The future of blood tests in cancer treatment
Dr. Isaac Garcia-Murillas The Institute of Cancer Research, UK
|
|
|
|
Rare disease clinical trials: challenges and best practices
Prof. Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research IRCCS, Italy
|
|
|
Featured Talks from Previous Releases
|
|
|
For more specially commissioned lectures:
|
For assistance, contact HSTalks subscriber support:
Subscriber Support, Henry Stewart Talks Ltd Tel: +44 (0) 20 7092 3480, Email: access@hstalks.com Address: 40/41 Museum Street, London WC1A 1LT, United Kingdom
|
Follow HSTalks
|
|
|
|
|